Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05113368
Title Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Afshin Dowlati, MD
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.